Impact of Genetic Testing on Risk-Management Behavior of Black Breast Cancer Survivors: A Longitudinal, Observational Study

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Annals of Surgical Oncology

• Publication date

  2019-11-01

• Fields of study

  Medicine, Sociology

• Identifiers
  DOI 10.1245/s10434-019-07982-9PMID 31677107PMCID PMC7145726
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Cultural, Folk, and Religious Beliefs and Practices on Delays in Diagnosis of Ovarian Cancer in African American Women

  2019cited by this paper
• Underutilization of Supplemental Magnetic Resonance Imaging Screening Among Patients at High Breast Cancer Risk

  2018cited by this paper
• Racial disparities in BRCA testing and cancer risk management across a population‐based sample of young breast cancer survivors

  2017cited by this paper
• Disparities in the use of screening magnetic resonance imaging of the breast in community practice by race, ethnicity, and socioeconomic status

  2016cited by this paper
• Randomized Noninferiority Trial of Telephone Delivery of BRCA1/2 Genetic Counseling Compared With In-Person Counseling: 1-Year Follow-Up.

  2016cited by this paper
• Recruitment of a Population‐Based Sample of Young Black Women with Breast Cancer through a State Cancer Registry

  2016cited by this paper
• Breast Cancer Survivors' Knowledge of Hereditary Breast and Ovarian Cancer following Genetic Counseling: An Exploration of General and Survivor-Specific Knowledge Items

  2015cited by this paper
• A high frequency of BRCA mutations in young black women with breast cancer residing in Florida

  2015cited by this paper
• Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON study

  2015cited by this paper
• High risk of in-breast tumor recurrence after BRCA1/2-associated breast cancer

  2014cited by this paper
• Comparison of risk management strategies between women testing positive for a BRCA variant of unknown significance and women with known BRCA deleterious mutations

  2014cited by this paper
• Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.

  2014cited by this paper
• Geographic access to breast imaging for US women.

  2014cited by this paper
• Risk management options elected by women after testing positive for a BRCA mutation.

  2014cited by this paper
• Long‐term outcomes of BRCA1/BRCA2 testing: risk reduction and surveillance

  2012cited by this paper
• Underutilization of BRCA1/2 testing to guide breast cancer treatment: Black and Hispanic women particularly at risk

  2011cited by this paper
• Effect of Genetic Counseling and Testing for BRCA1 and BRCA2 Mutations in African American Women: A Randomized Trial

  2010cited by this paper
• Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.

  2009cited by this paper
• Development and Validation of Measures of Religious Involvement and the Cancer Experience among African Americans

  2009cited by this paper
• Racial Distribution of Patient Population and Family Physician Endorsed Importance of Screening Patients for Inherited Predisposition to Cancer

  2009cited by this paper
• Uptake, Time Course, and Predictors of Risk-Reducing Surgeries in BRCA Carriers

  2009cited by this paper
• BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast‐ovarian cancer

  2009cited by this paper
• The counsellees' view of an unclassified variant in BRCA1/2: recall, interpretation, and impact on life

  2008cited by this paper
• Uptake and timing of bilateral prophylactic salpingo-oophorectomy among BRCA1 and BRCA2 mutation carriers

  2008cited by this paper
• Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.

  2008cited by this paper
• Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results

  2008cited by this paper
• Association between temporal orientation and attitudes about BRCA1/2 testing among women of African descent with family histories of breast cancer.

  2008cited by this paper
• Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.

  2008cited by this paper
• International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriers

  2008cited by this paper
• A systematic review of perceived risks, psychological and behavioral impacts of genetic testing

  2008cited by this paper
• Founder mutations in BRCA1 and BRCA2 genes.

  2007cited by this paper
• Risk Reduction and Health Promotion Behaviors Following Genetic Testing for Adult-Onset Disorders

  2007cited by this paper
• Bilateral prophylactic oophorectomy and bilateral prophylactic mastectomy in a prospective cohort of unaffected BRCA1 and BRCA2 mutation carriers.

  2007cited by this paper
• Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high‐risk and population risk women is ineffective

  2007cited by this paper
• Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer

  2006cited by this paper
• Cancer fatalism and breast cancer screening in African American women.

  2006cited by this paper
• Disparities in genetic testing: thinking outside the BRCA box.

  2006cited by this paper
• From cancer patient to cancer survivor : lost in transition

  2006cited by this paper
• Role of MRI in screening women at high risk for breast cancer

  2006cited by this paper
• Understanding locally advanced breast cancer: what influences a woman's decision to delay treatment?

  2005cited by this paper
• Attitudes about genetic testing and genetic testing intentions in African American women at increased risk for hereditary breast cancer

  2005cited by this paper
• The impact of receiving genetic test results on general and cancer‐specific psychologic distress among members of an African‐American kindred with a BRCA1 mutation

  2005cited by this paper
• The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.

  2005cited by this paper
• Family Physician Self-Efficacy With Screening for Inherited Cancer Risk

  2004cited by this paper
• Genetics in clinical cancer care: a promise unfulfilled among minority populations.

  2004cited by this paper
• Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort

  2004cited by this paper
• Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: differences across African American, Latina and Caucasian women.

  2003cited by this paper
• Sociocultural influences on participation in genetic risk assessment and testing among African American women.

  2003cited by this paper
• Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing

  2003cited by this paper
• Barriers to breast cancer control for African‐American women

  2003cited by this paper
• Perceptions of Genetics Research As Harmful to Society: Differences among Samples of African-Americans and European-Americans

  2002cited by this paper
• Goals of genetic counseling

  2001cited by this paper
• Cultural aspects of cancer genetics: setting a research agenda

  2001cited by this paper
• BARRIERS TO BREAST CANCER SCREENING: AN INTEGRATIVE REVIEW

  2000cited by this paper
• Relationships among breast cancer perceived absolute risk, comparative risk, and worries.

  2000cited by this paper
• Goodness of fit tests for the multiple logistic regression model

  1980cited by this paper

• Provider effects and racial inequities in breast cancer risk-management adoption: Findings from a community-based study of high-risk women.

  2025cites this paper
• Uptake of Risk-Reducing Surgeries in an International Real-World Cohort of Hispanic Women

  2024cites this paper
• Uptake of screening and risk-reducing recommendations among women with hereditary breast and ovarian cancer syndrome due to pathogenic BRCA1/2 variants evaluated at a large urban comprehensive cancer center

  2024cites this paper
• Breast Cancer Germline Genetic Counseling and Testing for Populations of African Heritage Globally: A Scoping Review on Research, Practice, and Bioethical Considerations

  2023cites this paper
• Use of breast surveillance between women with pathogenic variants and variants of uncertain significance in breast cancer susceptibility genes

  2022cites this paper
• Perspectives on Spanish language concordant cancer genetic counseling sessions from the Spanish‐speaking population

  2022cites this paper
• Clinical management among individuals with variant of uncertain significance in hereditary cancer: A systematic review and meta‐analysis

  2021cites this paper
• Genetic testing in Non-Hispanic Black women with breast cancer treated within an equal-access healthcare system.

  2021cites this paper
• “Being proactive, not reactive”: exploring perceptions of genetic testing among White, Latinx, and Pacific Islander Populations

  2021cites this paper
• Multiple approaches to enhancing cancer communication in the next decade: translating research into practice and policy.

  2021cites this paper
• Gamma secretase inhibitors inhibit ovarian cancer development and enhance olaparib’s anti-ovarian cancer activity and its mechanism

  2020cites this paper